Ginkgo Bioworks HoldingsDNABW 63 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates DNABW with a GF Score™ of 63/100. The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Ginkgo Bioworks Holdings ranks worse than 156739.66% on this metric.
The historical rank and industry rank for Ginkgo Bioworks Holdings's Days Inventory or its related term are showing as below:
During the past 7 years, Ginkgo Bioworks Holdings's highest Days Inventory was 63.97. The lowest was 6.90. And the median was 19.04.
DNABW's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.875 * Ranked among companies with meaningful Days Inventory only.
Ginkgo Bioworks Holdings's Days Inventory
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ginkgo Bioworks Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.00.
Ginkgo Bioworks Holdings (OTCPK:DNABW) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ginkgo Bioworks Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ginkgo Bioworks Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ginkgo Bioworks Holdings Days Inventory Related Terms
Ginkgo Bioworks Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DNABW vs AGMB, ACRS, RLMD: Days Inventory Comparison
For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginkgo Bioworks Holdings Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ginkgo Bioworks Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginkgo Bioworks Holdings (DNABW) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ginkgo Bioworks Holdings and its competitors. Over the past decade, Ginkgo Bioworks Holdings' Days Inventory has ranged from 6.90 to 63.97. According to the industry distribution chart, Ginkgo Bioworks Holdings ranks #999999 out of 638 companies in the Biotechnology industry.
Is Ginkgo Bioworks Holdings' Days Inventory too high?
Ginkgo Bioworks Holdings' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 6.90 to a high of 63.97. Based on the distribution chart, Ginkgo Bioworks Holdings ranks #999999 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Days Inventory compare to AGMB and ACRS?
According to the Biotechnology industry distribution chart, Ginkgo Bioworks Holdings ranks #999999 out of 638 companies for Days Inventory. This places Ginkgo Bioworks Holdings in the lower half of its industry. The industry median Days Inventory is 183.88. Historically, Ginkgo Bioworks Holdings' own Days Inventory has ranged from 6.90 to 63.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ginkgo Bioworks Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginkgo Bioworks Holdings's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Ginkgo Bioworks Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
63GF Score
Get the complete analysis for DNABW
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DNABW has been successfully added to your 
